First, the therapeutic effects of DPP4-inhibitors on CRC patients mentioned above were analyzed using the US population, but the effect of DPP4-inhibitors on the Chinese population is unknown, which will also serve as the reference for other Asian countries. This evidence concerns the gene DPP4 and colorectal carcinoma.